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YOUNG INVESTIGATORS' AWARDS
The following five abstracts are from the winning entries In the Young Investigators' Awards
Competition, 33rd Annual Scientific Session, American College of Cardiology, Dallas, Texas,
March 25-29, 1984.
in M's-II and III) comprised 68~4' of the basic,CL. In
M-III the postextrasystolic pause always equalled the
basic control CL. Results (in ms; mean + SD):
Data indicate that 1) during the sequential CL Changes
created by the pacing model, HPS responded in a highly
dynamic fashion whereas VM showed a modest cumulative
response; and 2) dispersion of refractoriness between HPS
and VM increased significantly during the post- (vs pre-)
extrasystolic beat. Thus, conditions for arrhythmogenesis
may be enhanced following postextrasystolic beats.
REGULATION AND STRUCTURE OF THE a- AND S- CARDIAC MYOSIN
HEAVY CHAIN GENES. V. Mahdavi, Ph.D., A.M. Lompre, Ph.D.,
A.P. Chambers, M.Sc. and B. Nadal-Ginard, M.D., Ph.D.,
F.A.C.C., Department of Cardiology, Children's Hospital,
Department of Pediatrics, Harvard Medical School,
Boston, MA 02115.
Two ventricular myosin heavy chains a- and S-MHCs which
exhibit different levels of ATPase activity are differen-
tially expressed during development and in response to
several pathological conditions. The relative distri-
bution of these two MHCs is in direct correlation with
the contractile performance of the heart. As an approach
to determine the molecular basis of these developmentally
and hormonally regulated MHC isozyme transitions, we have
used recently constructed MHC eDNA and genomic probes to
analyze the structure and quantitate the expression of
the cardiac a- and S- MHC genes. Using the Sl nuclease
mapping technique, we show that a- and S- MHC protein
transitions in the ventricular myocardium are regulated
at the level of the MHC mRNA availability. Thyroid
hormone induces the accumulation of a-MHC mRNA while it
represses S-MHC mRNA. Interestingly, the a-MHC gene is
also expressed in the atrium while the S-MHC gene is also
expressed in the slow-twitch skeletal muscle. We have
isolated the genes coding for a- and S-MHC ~~As. These
two genes are linked in the genome, 4 kilobase apart,
organized in a 5' to 3' orientation according to their
developmental expression. These two genes are very
closely related at the nucleotide level and yet their
expression is regulated in an antithetic fashion by
thyroid hormone. These facts shed new light on the bio-
chemical parameters involved in cardiac development and
cardiac response to different stimuli and should help to
prOVide a better understanding on the basic mechanism
regulating cardiac contractility.
CONTRACTILITY OF HYPERTROPHIED LEFT VENTRICLE
David Alyono MD, Robert J Bache MD FACC, Debora Parrish BS
WSteves Ring MD, Joseph R Schneider MD, Arthur J Crumbley
MD, and Robert W Anderson MD FACC, U of Minnesota, Mpls,MN
LV contractility in LV hypertrophy (LVH) has been reported to
be low, high, or normal. This controversy may in part due to
different models of LVH, in vitro vs in vivo study, and use of load
dependent indices. Using the 1000independent contractility index,
the end-systolic pressure-volume (EMAXpv) and equatorial cir-
cumferential stress-midwall circumference (EMAXsc) ratias, con-
tractility was evaluated in resting awake dogs with 4 models of
LVH: aortic banding (AOB)at 6-8 weeks old (gradient = 109 ±IO
mmHg), valvar aortic stenosis from plicating noncoronary aortic
valve cusp (AVS) at 6-8 weeks old (gradient = 82 ±14 mmHg), chro-
nic volume overload from aortacaval fistula (ACF), perinephritic
hypertension (HYP) (aortic pressure 208 ± 18/130 ± 5 mmHg) and
control dogs (CTL). Each group contained 12dogs. LVdimensions
and pressure were measured with sonomicrometers and microma-
nometer. End-diastolic pressure (EDP) was increased in AOB and
AVS; end-diastolic volume (EDV) and cardiac output (CO) were
increased in ACF. Although dp/dtmax was stable, EMAXpv and
EAMXsc were increased in AOB,unchonged in HYP,and depressed
in ACF; in AVS EMAXpvwas increased but EMAXsc was normal.
Thus, in response to a gradually increasing pressure-overlaod,
LVH was associated with preservation of contractility. However,
chronic volume overlood was associated with depressed contrac-
tilityand the normal (or increased) hemodynamic performance
(dp/dtmax, CO) appeared to be maintained by Starling reserve.
WR+ EDV EDP CO. dp/dtmax EMAXTrv EMAXsc
g71<9 rnrmmHg rTiTTniin mmHg/sec mmHgml cm=H20/cm
CTL 4.4 50 9 2424 2396 5.3 122
AOB 8.4** 49 18** 2500 2930 14.1** 246**
AVS 6.6** 46 18** 2203 2860 13.4* 158
ACF 6.3** 118** 14 6907** 2789 2.4** 92*
HYP 6.3** 71 13 2813 2755 9.5 180
+ LV weight to body weight ratio, * p < .05 ** p <.01 by ANOVA
INCREASED POSTEXTRASYSTOLIC DISPERSION OF REFRACTORINESS
BETWEEN HIS-PURKINJE SYSTEM AND VENTRICULAR MYOCARDIUM
IN MAN. Michael Lehmann, M.D., stephen Denker, M.D.,
Rehan Mahmud, M.D., Masood Akhtar, M.D., F.A.C.C. Uni-
versity of WI-Mount Sinai Medical center, Milwaukee, WI
The manner in Which human His-Purkinje system (HPS)
and ventricular myocardial (VM) refractoriness is al-
tered in postextrasystolic beats is unknown. Accord-
ingly, we devised a right ventricular pacing model Which
simulated the sequential abrupt cycle length (CL)
changes associated with an extrasystole-postextrasystole
sequence. In 15 patients retrograde BPS and VM relative
(R) and effective (E) refractory periods (RP's) were
determined (with the ventricular extrastimulus tech-
nique) during constant basic control drive (Method
(M)-I) and following simulated "extrasystolic" (M-II)
and 'postextrasystolic' (M-III) beats. The basic CL
(same for all 3 M's) ranged 500-700 ms (mean 6l3~74 ms),
whereas the extrasystolic coupling interval (identical
RRP HPS
RRP VM
ERP VM
Dispersion
Dispersion
M-I M-II M-III
331+37 245+37* 354+35*
264+23 251+22* 257+22**
245+21 233+23* 240+22**
(RRP HPS - RRP VM) 67+27 -8+22* 97+30*
(RRP HPS - ERP VM) 86+28 11+21* 114+29*
*p < .001 vs M-I **p ~ .002 vs M-I
N I N I
EPI ~T -17# -28**# +67*# +75*#
TOC m1 1.67 .67 3.68 .75
moo AT 1 -10** +28* +30*
TOC ~m1 1.74 .64 2.07 .34
TRANS AT -11 -10 +33* +37*
moo TOC 1.04 .95 .56 .45
At 60 min VT and VF were both still inducible in 5O'f,
in the L grou:g (37% in control), while only in 16% in
the P group t62:' in control). Both dI'U€i'l have IOOre
mrked effects on AT in the infarcted zone. In con-
clusion, propafenone increases AT uniforIJ!ll and breaks
VT by prOducing bidirectional block. Iddocame de-
creases AT but increases refractory period in the
non-infarcted zone. Devending on these effects, it TmJ"
facHitate or block iOOuction of VT.
THE CONTRAST BE'NEEN TRANSMURAL DISTRIBlJ.l'ION OF 14-e
LIOOCAINE AND 14-e PROPAFmONE AND THEIR EFFEX:TS ON
EPICARDIAL, moocARDIAL AND TRANSMURAL ACTIVATIONS
TIME3 m CHRONIC CANINE MYOCARDIAL INFARCTION.
Franco F. Naccarella MD; Jai B. ~, ~l FACC;
iIIII8in""""S. welntraub, JIIID, FACC; Richard H. nelfant,
MD, FACC, Mid-Atlantic Heart and Vascular Institute,
Presbyterian University of Pennsylvania Medical
Center, lm.ladellhia, PA ,
!he electro~iologi.caleffects of lidocaine (L) and
propafenone- (P) in <;:hronic MI in relation to tissue
<1rIl8 concentrations tTOC) are unknovn. Thus of 16 dogs
with one week old MI, 8.reqeived P 4 mg/kp, and 8 L 5rDi!ikgfollowed by 0.2 '!>i!/kg/min of either efrug for 60
am. Epicardial (EPI) IIBpping (>30 points) was per-
formed with a bipolar electrode. Endocardial (moo)
and translJ1lra1 (TRANS) IIBpping (>20 points) were per-
formed with 4 pairs of needle JWWlted bipqlar elec-
trodes. The %chanp,e in activation times (~A~) in
EPI, moo and TRANS'"" was evaluated in norllB1~N) and
infarcted (I) zones at co~tr9l and 60 min after d~.
Ventricular arrhythmias tVA) were studied with 00.
Results (* p(O.Of to L, ** P(O.OI to N zone, # P( 0.05
to moo):
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MYOCARDIAL MONOVALENT CATION TRANSPORT DURING TIlE
QUINIDINE-DIGOXIN INTERACTION. Natalie J. Warner,
M.D., J. Thomas Barnard, M.D., Edward B. Leahey Jr.,
M.D., Thomas J. Hougen, M.D., J. Thomas Bigger Jr.,
M.D., Thomas W. Smith, M.D., Columbia University,
New Yctrk, N.Y.
To study the relationship of the serum digoxin con-
centration (SDC) to digoxin effect during the
quinidine-digoxin interaction, we used 86-rubidium to
measure monovalent cation active transport in myocardi-
al biopsy samples from dogs. In a preliminary study,
we showed that quinidine did not affect myocardial ru-
bidium uptake. We then studied four groups of 13 dogs
each. Dogs in Group A received saline injections.
Dogs in Group B received digoxin to produce a mean SDC
of 1.17+0.16 ng/ml (s.d.) while dogs in Group C re-
ceived higher doses of digoxin and had a mean SDC of
2.37+0.45 ng/ml. Dogs in Group D received digoxin and
quinidine and had a mean SDC of 2.34+1.06 ng/ml. Com-
pared to control (Group A) values rubidium uptake was
decreased by 17% in dogs in Group B (p(0.05) and by 38%
in Group C (p(O.Ol vs Group A, p(O.Ol vs Group B).
Although dogs in Group D had the same mean SDC as the
dogs in Group C, rubidium uptake in Group D dogs was
decreased by only 17% compared to control (p(0.05 vs
Group A, p(O.Ol vs Group C). If these data can be ex-
trapolated to the clinical situation, they indicate
that reducing the dose of digoxin to maintain SDC in
the range usually regarded as therapeutic may result in
less than therapeutic digoxin effect in the presence of
quinidine. The complexity of the quinidine-digoxin in-
teraction makes recommendations about patient manage-
ment difficult. If quinidine and digoxin must be used
together, clinical parameters rather than SDC should be
used to determine the appropriate dose of digoxin.
